Showing 331-340 of 360 results for "".
- It's A Deal: Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernaesthetics.com/news/its-a-deal-baring-private-equity-asia-agrees-to-acquire-lumenis/2472848/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Kylie Jenner Sells Majority Stake in Beauty Business to Cotyhttps://modernaesthetics.com/news/kylie-jenner-sells-majority-stake-in-beauty-business-to-coty/2472846/Kylie Jenner sold a $600M majority stake in Kylie Cosmetics and Kylie Skin to Coty Inc. Under the terms of the agreement, Coty will acquire a 51 percent ownership in the partnership for $600M. The acquisition is expected to close in the third quarter of fiscal year 2020. Coty's
- British Plastic Surgeons to Vote on Brazilian Butt Lift Banhttps://modernaesthetics.com/news/british-plastic-surgeons-to-vote-on-brazilian-butt-lift-ban/2472830/It’s been called the deadliest cosmetic surgery procedure in the world, and now the British Association of Aesthetic Plastic Surgeons (BAAPS) is launching a formal safety review of Brazilian butt lifts that will culminate with a vote on whether to ban fat grafting buttock augmentation.
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://modernaesthetics.com/news/fda-approves-juvderm-voluma-xc-for-mid-face-injection-via-cannula/2471976/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p
- Soliton RAP Update: First Patients Treated in Cellulite Trialhttps://modernaesthetics.com/news/soliton-rap-update-first-patients-treated-in-cellulite-trial/2471872/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of
- Revance Appoints Brand Strategist Jill Beraud to Board of Directorshttps://modernaesthetics.com/news/revance-appoints-brand-strategist-jill-beraud-to-board-of-directors/2471899/Jill Beraud is now a member of Revance Therapeutics, Inc.'s Board of Directors. Ms. Beraud brings more than 25 years’ experience building luxury, fashion, beauty, and consumer brands. Ms. Beraud will also chair a newly-formed Revance Brand St
- Sciton Introduces JOULE X at ASLMShttps://modernaesthetics.com/news/sciton-introduces-joule-x-at-aslms/2471929/Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the company’s latest multi-device platform. It works
- ASPS 2018 Data: Plastic Surgery is on the Rise and It's All About the Bodyhttps://modernaesthetics.com/news/asps-2018-data-plastic-surgery-is-on-the-rise-and-its-all-about-the-body/2471942/It’s official. Plastic surgery is on the rise. There were nearly 18 million more cosmetic procedures performed in 2018 than 2017, and this number has risen steadily over the past five years, according to the 2018 statistics from the
- Botox's New “Own Your Look" Campaign Targets Millennialshttps://modernaesthetics.com/news/botoxs-new-own-your-look-campaign-targets-millennials/2471957/Allergan’s new direct-to-consumer campaign, "Own Your Look," aims to address the most common misconceptions around Botox Cosmetic (onabotulinumtoxinA) among millennials, namely the fear of looking frozen. This is the first campaign from the brand created specifically to ad